Acupuncture at the P6 acupoint for pain control in teenagers after triple repair surgery of patellar dislocation

Acupuncture at the P6 acupoint for pain control in teenagers after triple repair operation of patellar dislocation: a randomized, placebo-controlled, double-blind trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN75218899

Enrollment

Registered

2024-05-14

Start date

2024-05-15

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain control of patellar dislocation patients undergoing triple repair surgery Surgery

Interventions

Patients will be randomly allocated to an experimental group and a control group using a random number table. An indwelling press needle (0.2 x 1.5 mm, Pyonex, Seirin Corporation, Shizuoka, Japan) wi

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Adolescent patients aged 13-18 years 2. Patients who underwent this procedure for the first time 3. Patients with unilateral surgery 4. Junior high school or above 5. Patients undergoing general anesthesia 6. No previous history of opioid and psychotropic medication 7. No previous history of smoking or alcoholism 8. Informed consent

Exclusion criteria

Exclusion criteria: 1. Changes in surgical methods for various reasons 2. Patients with combined cardiovascular and cerebrovascular disease 3. Patients with mental cognitive impairment or a history of mental illness 4. Skin damage in the needle prick site or patients with infection 5. Femoral nerve block in anesthetized patients 6. Patients with forced braking for various causes 7. Patients who cannot adhere to all treatment and follow-up

Design outcomes

Primary

Measure	Time frame
Pain intensity measured using visual analogue score (VAS) at 24 h, 48 h, and 72 h after the rehabilitation exercise	—

Secondary

Measure	Time frame
1. Intensity of maximum and minimum resting pain measured using VAS at 24 h, 48 h, 72 h after surgery 2. Total amount of additional analgesics used: the researchers will record the total amount of different drugs according to the doctor's order after surgery for 72 hours. 3. Rate of analgesic side effects: if the patient displays any analgesic side effect symptoms, it will be recorded as "once", such as vomiting once or twice, etc. 4. Satisfaction of patients with postoperative analgesia measured using a visual analogue scale at discharge 5. Quality of life items disturbed by pain, measured by asking and recording the patients' subjective cognition every morning until the press needle is removed 6. Successful blinding of patients: a special researcher will ask the question "Do you know which group are you in?" when they finish data collection. The researcher judges whether the blinding is a success or not according to the answer.	—

Measure

Time frame

1. Intensity of maximum and minimum resting pain measured using VAS at 24 h, 48 h, 72 h after surgery 2. Total amount of additional analgesics used: the researchers will record the total amount of different drugs according to the doctor's order after surgery for 72 hours. 3. Rate of analgesic side effects: if the patient displays any analgesic side effect symptoms, it will be recorded as "once", such as vomiting once or twice, etc. 4. Satisfaction of patients with postoperative analgesia measured using a visual analogue scale at discharge 5. Quality of life items disturbed by pain, measured by asking and recording the patients' subjective cognition every morning until the press needle is removed 6. Successful blinding of patients: a special researcher will ask the question "Do you know which group are you in?" when they finish data collection. The researcher judges whether the blinding is a success or not according to the answer.

—

Countries

China

Contacts

Public ContactPengcheng Li

16699411@qq.com+86 (0)18980601911

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026